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Development of tbrombolytii therapy. During the Past 
decade thrombolytic therapy of acute myocardial infarction 
has been studied extensively and its e0icacy has been proved 
unequivocally. It has been demonstrated that several agents 
induce patency of previously occluded coronary arteries 
when administ&ed either dire& into the corm& artery or 
into a peripheral vein (I). Prolonaatian of life has been 
recorde> in several large clinical~ trials of thrombolytic 
agents administered intravenously (2-5). 
As the efficacy of thmmbolytic therapy has been estab- 
lished, investigators have intensified studies of techniques 
designed to enhance the rapid achievement of vascular 
~ateky and the maintenaoe~ of the benefits achieved ini- 
tially because reocclusion and reinfaction durine the initial 
hos&dization are not mfrequent (II. Accordingly, cardiac 
catheterization. coronary angiography and coronary angio- 
plasty have been studied as techniques employed early in the 
course of the care of patients with myoardial infarction 
either by perfonoing primary aogioplasty or utilizing these 
techniques to consolidate the benefits of thmmbolysis (6- 
IO). Despite the ubvious logic that a widely patent vessel 
must provide better initial salvage and lower reocclusion 
rates, randomized studies (6-10) have not shown that early 
aggressive management of myoeardial infarction has any 
clear long.temt benefits compared with thmmbolysis alone 
with respect to survival, reinfarction or preservation of 
myocardial function. 
As thrombolytic therapy of acute myocardial infarction 
has evolved, initially it war studied and used primarily in 
academic and tertiary medical centers. in part because ofthe 
expertise of the inkigators and in part because of the 
mccssity for immediate access to angiography for the ad- 
ministration of thrombalytic agents by the iotracomnary 
route and for the documentation of the eftkacy of throm- 
holylic rherapy. As intravenous!brombolytic therapy :zined 
acceptance. the feasibility and s&y of performing throm- 
bolyl~c therapy in community hospitals wes estab!ishzd. at 
least when rapid transport to tertiary medical centen was 
wadable and employed routmely II I-14). 
The present study oo thromt&ytic thcrepy in cormnunity 
hospitals. A “conservative management stntegy” has 
cvolvcd m which coronary angiogrdphy and subscqoent 
revasculariwtion are employed after tbrombolysn only If 
rccnrrcnt ischemia is detected. This approach has proved 
usefui in an environment in which access to invasive proce- 
dure, was readily available and was used relatively fre- 
quently (cardiac catheterization was performed in 32.7% of 
patients in the conservative management am, during the first 
I4 days in the Thrombolysis in Myocardinl Infarction [TIM11 
IIB study [lS.l61). However. a report in this issue of the 
Journal (17) indicates that. although access to invasive 
pmcedures must be established, it need not be available 
instantaneously to maintain the benefits of thrombolysis. In 
the community hospitals that enrolled patients in this TIMI 
IIB study (17). access to invasive procedures at a regional 
hospital was established before the initiation of the study. 
Access to catheterization was available in <4 h in only 64% 
of the community hospitals and in 16 h in 76% of these 
institutions. Despite what some might consider relatively 
long delays in access to a catheterization laboratory. out- 
comes in community hospitals (without angiographic facili- 
ties) and in tertiar, hospitals (with angiographic fecilities, 
presumably available on very short notice) were comparable 
at 42 days and I year after infarction with respect to 
mortality. reinfarction and frequency of angina. Patients 
randomized at tertiary and community hospitals also had 
comparable outcomes with regard to rest and exerwe ejec- 
tion fraction and the percentage ofpatients with an abnormal 
exercise test when each was performed before hospital 
dischartx and6 week after infa&ion. These findings should 
allay fears that some might have that high quality care for 
Patients with myocardial infarction can only be delivered at 
tertiary “high tech” medical centers. It must be recognized, 
however, that the community hospitals that enrolled patients 
in the National Institutes of Health-sponsored TIM1 11B 
study were carefully evaluated before being accepted as 
centers that enrolled patients in this research protocol. 
Therefore. these “community hospitals” may only represent 
the most academically oriented of community hospitals that 
have close ties to terdary medical centers. 
Perhaps scrprisingJy, compamble clinical outcomes were 
observed in tbe two types of institutions despite the longer 
potential time required to initiate urgcat or emergent cardiac 
catheterization in patients randami_:d in community hospi- 
tals and. importantly. despite a more aggressive iuvd5ive 
approach to patient care nt tertiary medical centers. A higher 
percentace of patients enrolled m tertiary centers underwent 
&thet&atio~ (46% versus 31%). rec&ved coronary angio- 
plasty 08% versus 10.9%) and coronary artery bypass 
surge,, (11.8% versus 7.8%). even though all patients in- 
cluded m the report of Feit et al. 117) were assigned to a 
“c0nrervat1ve stmlcgy.” 
Possible limitations of the study. Although the TIM1 IIB 
protocol specified the conditions under which patients could 
have invasive procedures performed in the “conservative 
management arm.” substantinl physician judgment was re- 
quired to dcterminc the frequency and severity of chest pain 
after infarction: the severity. extent and duration of new 
electrocardiographic abnormalities; and the severity ofother 
clinical events that were sufficient o wrn’rant rhe initiation of 
invasive procedures. The perceution of what constitutes an 
indication for clinically indic&d catheterization was dif- 
ferenl between nhvsicians in TIM1 IIB enrolline oatients in 
tertiary as oppo& to community hospitals. The-f;nding that 
long-term outcotnes were comparable in patients enrolled in 
both types of instttutions underscores the fact that currently 
there are no good rxiteria for deciding when patients “need” 
angiography early after infarction and emphasizes our inabil- 
ity to identify clearly patients where p~stinfarclion chest 
pain is ischemic. as opposed to due to pericarditis or other 
causes. 
Although major demographic characteristics were corn- 
parable between patients enrolled in TIM1 IIB in community 
and tertiary hospitals. there could have been differences 
between patients admitted to the two types of institutions 
based on self-selection or referral p&t&s. There might 
also have been differences in monitoring equipment. strfing 
patterns or hospital procedures that might have enhanced 
the detection of ischemic episodes in teniary hospitals. 
thereby precipitating the aggressive course taken at these 
institutions. Alternatively, as suggested by Feit et al. (l7), 
investigalors at tertiary centers might simply have had a 
LLlo~er threshold” for angiography (16). perhaps due in part 
to the obvious availability of this technique. Once angiugra- 
phy was performed, comparable percentages of such pa- 
tients proceeded to coronary angioplasty or coronary artery 
bypass surgery, or both, regardless of the type of hospital in 
which patients were initially randomized. 
ClinIcal implications. If one cx~rapolates from the TIM! 
IIB experience to a pattern of care across the United States, 
the economic impact of even the moderately more uggres- 
sive slrdlegy employed in tertiary centers in the ‘*conserve- 
tive management arm” would be substantial. With an esti- 
mated instance of acute myocardial infarction of 1.6 to 1.7 
milfion annually in the United States and an estimated 
utilization of thrombolyais of IS% to 20%. one can estimate 
that nearly 2SO.tXil patients will receive thrombolytic ther- 
apy in !he United States in 1990. If catheterization were 
performed in 47% (as in the tertiary hospitalsl compared 
with the 31% (performed in the community hospitalsl, then 
nearly 4O.uoO extra cardiac catheterizations would he per- 
formed because of the “lower threshold” for performing 
these procedures. Employing simdar logic and the fre+ency 
of coronary artery angioplasty and bypass operations iner- 
formed in the two types ofcen& in the report by Feit et .+I. 
(17) (in the “conservative rnanawnent artn”~. one WCL’~ 
expect au extra 17.750 angiop&ies and 14,250 byp. ‘a 
grafting procedures. The economic cost of these extra prs- 
cedures tcatheterization. angioplasty and surgery) would he 
between $550 and %f.QO million per year. Furthermore, there 
would be additional costs due to prolonged hospitalization. 
unavoidable bleeding complications and increased require- 
ments for transfusion with their potenltal for further compli- 
cations and costs. Ii the “invasive approach’* of TIMI IfB 
were employed. angiography. angioplastr nnd coronary x- 
lery bypass surgery would be even more frequent and costs 
would increarr cwn more drastically. Despite this enormous 
cost. there would be no measurable difference in short- or 
long-term outcome (10.15-17). 
Conclusions. The data presented in the report of Feit et 
al. (17) in this issue of the Journal underscore the importance 
of the findings of the overall TIM1 IIB study in which the 
efficacy of conservative management strategy after throm- 
bolytic therapy has been demonstrated clearly (15-17). Al- 
though some may have had concerns that measurable delays 
between the detection of ischemic events and tho perfor- 
mance of engiography and angioplasty might have impaired 
short- and long-term prognosis, this clearly has not been the 
case. In fact. the conservative management of patients in lhe 
community hospitals in TIM1 IIB a~wars to generate as 
favorable an o&ome as that which’is experie&ed in pa- 
tients treated somewhat more aggressively in the tertiary 
medical centers of this country. Many. perhaps most. phy- 
sicians treating patients aith tnyocardial infarction with 
thrombolytic agents feel a “need to know the anatomy” and 
have a desire to have unequivocal evidence of the presence 
or absence of recanalizatian of the infarct-related artery. 
Nevertheless, it is the fervent hope of many physicians 
that more effective anilthmmbotic therapy currently under 
development ultimatel~~ may reduce the incidence of re- 
occlusion and that the ~mple&ttation of better noninvasive 
markers of recanalization and reocclusion will reduce the 
pressure to perform predischarge angiography to define the 
vascular anatomy. There is now compelling evidence that 
an aggressive invasive approach to the management of 
patients receiving thmmbolytic thempy and the resultant 
“occulostenotie reflex” (Top01 E. personal communication) 
leads to an increased frequency of revasculatization pmce- 
dures that do not appear to influence long-term prognosis 
favorably in the absence of spontaneous or exercise-induced 
ischemia. 
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